Dr P Nylander Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2005-07-12 and was issued with the 115245246 ACN. Its Australian Business Number is 73115245246. Since 2019-05-06, the company is headquartered in QLD, post code 4212. The previous headquarters were located in TAS 7170 (from 2014-09-12 to 2019-05-06), TAS 7170 (from 2010-06-14 to 2014-09-12), and TAS 7172 (from 2005-07-13 to 2010-06-14). Dr P Nylander Pty Ltd was registered for the GST on 2005-07-12. Dr P Nylander Pty Ltd has been using the Dr P Nylander Pty Ltd trading name since 2005-07-12 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2019-05-09.
| Status | From | To |
|---|---|---|
| Active | 12th July 2005 | current |
| Name | From | To |
|---|---|---|
| Dr P Nylander Pty Ltd | 12th July 2005 | current |
| Name | From | To |
|---|---|---|
| Dr P Nylander Pty Ltd | 12th July 2005 | current |
| Location | From | To |
|---|---|---|
| QLD 4212 | 6th May 2019 | current |
| TAS 7170 | 12th September 2014 | 6th May 2019 |
| TAS 7170 | 14th June 2010 | 12th September 2014 |
| TAS 7172 | 13th July 2005 | 14th June 2010 |
| TAS 7172 | 12th July 2005 | 13th July 2005 |
| Status | From | To |
|---|---|---|
| Registered | 12th July 2005 | current |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.